Effects of somatostatin on insulin and glucagon in patients with insulinoma
- 3 Downloads
Effects of somatostatin on fasting and arginine- or tolbutamide-stimulated insulin release were studied in four patients with insulinoma. Somatostatin (bolus or bolus + infusion) reduced fasting insulin values in all patients; insulin response to tolbutamide was partially reduced in two patients; somatostatin bolus impaired the insulin response to arginine. Fasting glucagon levels and glucagon response to arginine were also reduced by somatostatin. These results indicate the potential usefulness of somatostatin in the diagnosis of insulinoma even if its effect on insulin is only partial.
Key-wordsGlucagon insulin insulinoma somatostatin tolbutamide arginine
Unable to display preview. Download preview PDF.
- 13.Berchtold P., Berger M., Wiegenman W., Cuppers M.J., Grunneklee D., Reminwein D., Gries F.A., Zimmermann M. Serum insulin suppression by somatostatin, diazoxide and Phenytoin in insulinoma patients. V International Congress of Endocrinology, Hamburg July 18-24, 1976, Abstract 229.Google Scholar
- 16.Hoffman W.S. A rapid photoelectric method for the determination of glucose in blood and urine. J. Biochem. (Tokyo), 120: 51, 1937.Google Scholar